A challenge trial can streamline testing of hepatitis C vaccines - STAT
Price: $ 22.50
4.5(155)
With a cure for #hepatitisC in hand, now is the time to use challenge trials to test new vaccines to prevent this debilitating and even deadly disease.
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters
Rating of US states in terms of access to hepatitis C virus (HCV)
mRNA vaccines in disease prevention and treatment
Control and Eradication Strategies of Hepatitis B Virus: Trends in Microbiology
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users
Global hepatitis C elimination: an investment framework - The Lancet Gastroenterology & Hepatology
POWERING VACCINE R&D: OPPORTUNITIES FOR TRANSFORMATION - The Sabin-Aspen Vaccine Science & Policy Group
In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
Hepatitis C Virus Clearance Cascade — United States, 2013–2022
